Lab members

• Karim Fizazi (PU-PH Univ. Paris-Saclay)
• Yohann Loriot (MD-PhD, GR)
• Anne Chauchereau (CRCN-HDR INSERM)
• Virginie Quidville (Research Engineer, GR)
• Ludovic Bigot (Engineer, GR)
• Sandrine Agoussi (Technician, GR)
• Jonathan Sabio (Technician, GR)
• Guiseppina Claps (Post-Doctoral fellow, GR)
• Ramdane Guemiri (Post-Doctoral fellow, GR)
• Shensi Shen (Post-Doctoral fellow, GR)
• Michaël Cerezo (Post-Doctoral fellow, GR)
• Luce Dreno (PhD student Univ. Paris-Saclay)

Major publications

• Shen S et al. An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells. Nat Commun. 2019; 10(1):5713.
• Cerezo M, Guemiri R et al. Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma Nat Med. 2018 (12):1877-1886

Non genomic adaptation to anticancer therapies

This team belongs to the UMR 981 - Molecular predictors and new targets in oncology

Lab members

• Ken Olaussen (MCU Univ. Paris-Saclay, HDR)
• Françoise Farace (Ingénieure IGR, HDR)
• Benjamin Besse (PU-PH Univ. Paris-Saclay)
• Christophe Massard (PU-PH Univ. Paris-Saclay)
• David Planchard (MD IGR)
• Patrycja Pawlikowska (Ingénieure de recherche IGR)
• Floriane Brayé (Ingénieure d’études IGR)
• Marianne Oulhen (Ingénieure d’études IGR)
• Pauline Tesson (Technicienne IGR)
• Agathe Aberlenc (Technicienne IGR)
• Natalia Pinzon (Post-Doctorante IGR)

Major publications

1: Facchinetti F, Hollebecque A, Bahleda R, Loriot Y, Olaussen KA, Massard C, Friboulet L. Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors. Clin Cancer Res. 2019 Oct 4. doi: 10.1158/1078-0432.CCR-19-2035. [Epub ahead of print] Review. PubMed PMID: 31585937.

Genetic tumor adaptation to kinase inhibitors

This group belongs to the UMR 981 - Molecular predictors and new targets in oncology

Synthèse d’actualités scientifiques liées au Covid-19, réalisée et commentée par des experts de Gustave Roussy.